A Study of Metabolic Agents Following Brain Radiation
Launched by MAYO CLINIC · Nov 21, 2023
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Radiographic evidence or histopathologic confirmation of CNS malignancy, with or without prior resection.
- • Provide written informed consent for the current study.
- • Willing to undergo at least one MRI (and possibly more at PI discretion) with proton and/or phosphorus magnetic resonance spectroscopy analysis.
- Exclusion Criteria:
- • Vulnerable populations: pregnant or nursing women (Arm B exempt), prisoners, mentally handicapped.
- • Cardiac pacemaker or artificial heart valve
- • Metal plate, pin, or other metallic implant
- • Intrauterine device, such as Copper-7 IUD
- • Insulin or other drug pump
- • Non-titanium aneurysm clips
- • Previous gunshot wound
- • Cochlear implant or other hearing device
- • Employment history as a metalworker (had metal in eye)
- • Permanent (tattoo) eye-liner
- • For FDG-PET specifically: Fasting blood sugar level greater than 200mg/dl
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Rochester, Minnesota, United States
Patients applied
Trial Officials
Terry C Burns, MD, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported